Using genetic predisposition data alongside clinical evidence supports a more personalized conversation with your provider about which GLP-1 formulation (injection or oral) and dosing commitment might align best with your tolerance profile and lifestyle
In February 2026, Novo Nordisk filed a federal patent infringement suit against Hims & Hers Health, one of the largest telehealth distributors of compounded semaglutide, in the U.S
Tran Le, MD, DABOM, who is board-certified in obesity medicine
At Neighborhood Medical Center, we are committed to providing cutting-edge treatments that can improve quality of life, support overall health, and address a range of medical conditions
No, weight loss injections do not replace statin therapy in patients with established indications for lipid-lowering treatment